Open AccessThe role of interferon in the treatment of acute hepatitis C
Author(s) -
Jasmina Simonovic-Babic,
Dragan Delić,
Neda Švirtlih
Publication year - 2007
Publication title -
medicinski pregled
Language(s) - English
Resource type - Journals
eISSN - 1820-7383
pISSN - 0025-8105
DOI - 10.2298/mpns0708322s
Subject(s) - medicine , ribavirin , hepatology , interferon , gastroenterology , hepatitis c virus , alanine aminotransferase , immunology , bilirubin , liver disease , virus
Progression from acute to chronic HCV infection occurs in 50% to 84% of cases. Even the latest approach--combination therapy with pegilated interferon alfa 2-a or 2b and ribavirin--eliminates the virus in only 54% to 56% of cases with chronic infection. The aim of this study is to determine whether treatment during the acute phase prevents the development of chronic infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom